Active Ingredients
Benzoyl Peroxide 9.8%
The following Structured Product Label (SPL) was submitted to the FDA by Prugen, Inc. for the product Benzepro (NDC 42546-015). This document serves as the official prescribing information, containing essential scientific data and clinical materials required for healthcare providers and patients.
This specific version of the label includes detailed information regarding active ingredients, purpose, uses, warnings, do not use if you, when using this product, stop and ask a doctor if, keep out of reach of children., and other regulatory disclosures. Use the navigation below to review specific sections of the FDA submission.
Benzoyl Peroxide 9.8%
Acne Treatment
Indicated for the topical treatment of mild to moderate acne vulgaris
For external use only
If swallowed, get medical help or contact a Poison Control Center right away.
See package insert for full prescribing information
Prime can before initial use: See package insert Before Each Use: Shake vigorously
During Use: Holding can upright, dispense into palm of hand and apply to affected area as directed by physician.
BHT, C12-15 alkyl benzoate, cetostearyl alcohol, citric acid, dimethicone, disodium EDTA, emulsifying wax, glycerin, methylparaben, povidone, propylene glycol, propylparaben, purified water, sodium citrate, steareth-10, stearic acid, trolamine. Also contains: Propellant HFA-134A (1, 1, 1, 2-tetrafluoroethane).
Questions? 866-696-8525
Manufactured for:
PruGen, Inc.
Pharmaceuticals
8714 E Vista Bonita Dr
Scottsdale, AZ 85255 REV 1.2
NDC 42546-015-10
Rx only
BenzePrO®
Short Contact Foam
benzoyl peroxide
9.8%
For topical treatment
of mild to moderate
acne vulgaris
Net Weight 100 g
Will not dispense entire contents.
Container is overfilled to guarantee
dispensing at least the listed amount.
PRUGEN™
PHARMACEUTICALS
* Please review the disclaimer below.